Clinical Trials Browser

Medulloblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07492316 2026-03-25

PNOC020 rMB

Phase 1 Not yet recruiting

24 enrolled

CNS

Medulloblastoma

NCT06639607 2026-03-10

PRiME II

Phase 1/2 Not yet recruiting

68 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

NCT07390539 2026-02-05

B7-H3.CD28Z.CART in CNS Neoplasms

Phase 1 Not yet recruiting

70 enrolled

CNS

Brain Neoplasms, Ependymoma, Medulloblastoma, Meningeal Neoplasms, Pinealoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT07346157 2026-01-16

PNOC044

Phase 1/2 Not yet recruiting

69 enrolled

CNS

Medulloblastoma

NCT07291102 2025-12-18

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

Phase 3 Not yet recruiting

96 enrolled

CNS

Medulloblastoma

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

40 enrolled

CNS

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT06485908 2024-07-03

MEPENDAX

Phase 1/2 Not yet recruiting

40 enrolled

CNS

Ependymoma, Medulloblastoma

NCT06396481 2024-05-02

CSAγδTBMG

Phase EARLY_PHASE1 Not yet recruiting

25 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Clinical Trials

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

PNOC020 rMB

PRiME II

B7-H3.CD28Z.CART in CNS Neoplasms

PNOC044

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

EViDENCE-BT

MEPENDAX

CSAγδTBMG